Summary
- Profile Type
- Technology offer
- POD Reference
- TODE20250228014
- Term of Validity
- 28 February 2025 - 28 February 2026
- Company's Country
- Germany
- Type of partnership
- Research and development cooperation agreement
- Investment agreement
- Targeted Countries
- All countries
Contact the EEN partner nearest to you for more information.
Find my local partner
General information
- Short Summary
- A new development by a German university offers a promising solution: a therapeutic hydrogel with antimicrobial properties that combats infections - including those caused by multi-resistant bacteria - and detects them at an early stage. The university offers a license agreement and a technology cooperation agreement.
- Full Description
-
The effective treatment of chronic and infected wounds remains a significant challenge in healthcare. The wound care technology market continues to grow steadily, driven by an aging population and the rise of chronic conditions such as diabetes, which increase the demand for innovative solutions. At the same time, there is a strong focus on developing safe and effective products that promote healing and reduce the risk of complications such as infections. Of particular interest are solutions which also prevent and combat infections by multi-drug resistant bacteria.
The invention by a German university introduces a novel solution: a therapeutic hydrogel specifically designed for wound dressings.
Key features of the hydrogel-polymer:
Antimicrobial action: The polymer side chains are modified with antimicrobial proteins such as SAAP148, which effectively combat infections including infections by multidrug resistant bacteria.
Bacterial detection: An optional color indicator can be integrated to detect presence of bacterial enzymes early through visible changes.
Safe application: All active components, including the photocrosslinker, are covalently bonded to the polymer network, preventing the diffusion of substances into the wound and enhancing patient safety. This innovation offers a versatile and advanced solution for modern wound care.
The versatility of the therapeutic hydrogel offers significant benefits to companies and institutions across sectors such as healthcare, elderly care, veterinary medicine, cosmetics, and research. The university offers interested companies the opportunity to license this technology or collaborate on its further development in partnership with the university. Additionally, the technology can be explored further within the framework of a research project, with the active participation of interested companies. - Advantages and Innovations
-
The competitive advantages of this invention are:
- High safety through covalent bonding of materials
- Dual functionality: Antimicrobial action and infection detection
- Wide range of applications - Stage of Development
- Lab tested
- Sustainable Development Goals
- Goal 3: Good Health and Well-being
- IPR status
- IPR applied but not yet granted
- IPR notes
- A patent application has been filed with the German Patent and Trademark Office, and additional international applications are possible within the priority year.
Partner Sought
- Expected Role of a Partner
- The versatility of the therapeutic hydrogel offers significant benefits to companies and institutions across sectors such as healthcare, elderly care, veterinary medicine, cosmetics, and research. The university offers interested companies the opportunity to license this technology or collaborate on its further development in partnership with the university. Additionally, the technology can be explored further within the framework of a research project, with the active participation of interested companies.
- Type and Size of Partner
- SME 11-49
- SME 50 - 249
- Other
- SME <=10
- Big company
- Type of partnership
- Research and development cooperation agreement
- Investment agreement
Dissemination
- Technology keywords
- 06001013 - Medical Technology / Biomedical Engineering
- 06001017 - Surgery
- Market keywords
- 05007007 - Other medical/health related (not elsewhere classified)
- 05007002 - Pharmaceuticals/fine chemicals
- Targeted countries
- All countries
